TCMBANKGE008312 |
CKAP4 |
CLIMP-63; CLIMP63; ERGIC-63; p63 |
cytoskeleton associated protein 4 |
TCMBANKGE000580 |
RICTOR |
AVO3; PIA; hAVO3 |
RPTOR independent companion of MTOR complex 2 |
TCMBANKGE000568 |
MET |
AUTS9; DFNB97; HGFR; RCCP2; c-Met |
MET proto-oncogene, receptor tyrosine kinase |
TCMBANKGE000825 |
CDKN1B |
CDKN4; KIP1; MEN1B; MEN4; P27KIP1 |
cyclin dependent kinase inhibitor 1B |
TCMBANKGE000898 |
MYC |
MRTL; MYCC; bHLHe39; c-Myc |
MYC proto-oncogene, bHLH transcription factor |
TCMBANKGE015151 |
HPGDS |
GSTS; GSTS1; GSTS1-1; PGD2; PGDS |
hematopoietic prostaglandin D synthase |
TCMBANKGE004101 |
RPE65 |
BCO3; LCA2; RP20; mRPE65; p63; rd12; sRPE65 |
retinoid isomerohydrolase RPE65 |
TCMBANKGE001073 |
PTGS2 |
COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 |
prostaglandin-endoperoxide synthase 2 |
TCMBANKGE004266 |
AR |
AIS; AR8; DHTR; HUMARA; HYSP1; KD; NR3C4; SBMA; SMAX1; TFM |
androgen receptor |
TCMBANKGE007368 |
GSTP1 |
DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI |
glutathione S-transferase pi 1 |
TCMBANKGE001106 |
MTOR |
FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS |
mechanistic target of rapamycin kinase |
TCMBANKGE002052 |
CIB1 |
CIB; CIBP; KIP1; PRKDCIP; SIP2-28 |
calcium and integrin binding 1 |
TCMBANKGE007509 |
KRT5 |
CK5; DDD; DDD1; EBS2; K5; KRT5A |
keratin 5 |
TCMBANKGE014230 |
RIT2 |
RIBA; RIN; ROC2 |
Ras like without CAAX 2 |
TCMBANKGE007816 |
UVRAG |
DHTX; VPS38; p63 |
UV radiation resistance associated |
TCMBANKGE011987 |
TP63 |
AIS; B(p51A); B(p51B); EEC3; KET; LMS; NBP; OFC8; RHS; SHFM4; TP53CP; TP53L; TP73L; p40; p51; p53CP; p63; p73H; p73L |
tumor protein p63 |
TCMBANKGE009074 |
EBP |
CDPX2; CHO2; CPX; CPXD; MEND |
EBP cholestenol delta-isomerase |
TCMBANKGE000071 |
BTG2 |
APRO1; PC3; TIS21 |
BTG anti-proliferation factor 2 |
TCMBANKGE002961 |
DYNLL1 |
DLC1; DLC8; DNCL1; DNCLC1; LC8; LC8a; PIN; hdlc1 |
dynein light chain LC8-type 1 |
TCMBANKGE012224 |
VDR |
NR1I1; PPP1R163 |
vitamin D receptor |
TCMBANKGE000992 |
KLK3 |
APS; KLK2A1; PSA; hK3 |
kallikrein related peptidase 3 |